EMA Head On Transparency, Affordable Innovation, And What Patients Really Need
Executive Summary
EMA will reinforce its role as a global reference authority and help build regulatory capacity in less experienced countries, Guido Rasi says in outlining his five-year priorities for the agency. He hopes regulatory efficiencies might contribute to lower drug prices.